The impact of the mode of adjuvant therapy on intermediate-risk and high-risk uterine endometrial cancer: A retrospective multicenter study

The impact of the mode of adjuvant therapy on intermediate-risk and high-risk uterine endometrial cancer: A retrospective multicenter study - uterine endometrial adjuvant therapy study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016005

Enrollment

2000

Registered

2014-12-19

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with intermediate-risk and high-risk uterine endometrial cancer who underwent operation at the participanting hospitals between January 1, 1996 to December 31, 2013.

Exclusion criteria

Exclusion criteria: Patients with incomplete clinicopathological data. Patients with more thean 1 primary tumor.

Design outcomes

Primary

Measure	Time frame
Progression-free survival	—

Secondary

Measure	Time frame
Local failure rate and distant failure rate	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactMayu Omori

Mie University School of Medicine Department of Obstetrics and Gynecology

mayu-o@clin.medic.mie-u.ac.jp059-232-1111

Outcome results